Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-006303
Date:2020-05-15
Issuer: ABIOMED INC (ABMD)
Original Submission Date:

Reporting Person:

HOWLEY MICHAEL G
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE DANVERS, MA 01923

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $.01 PAR VALUE 2020-05-15 F 1,486 d $184.27 31,352 direct
COMMON STOCK, $.01 PAR VALUE 2020-05-15 F 267 d $184.27 31,085 direct
COMMON STOCK, $.01 PAR VALUE 2020-05-16 F 210 d $184.92 30,875 direct
COMMON STOCK, $.01 PAR VALUE 2020-05-16 F 620 d $184.92 30,255 direct
COMMON STOCK, $.01 PAR VALUE 2020-05-15 0 $0.00 20,510 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 21.55 2020-05-15 deemed execution date 0 ( ) 2015-05-14 2024-05-14 common stock 0 $21.55 7,500 direct
STOCK OPTION (RIGHT TO BUY) 23.15 2020-05-15 deemed execution date 0 ( ) 2014-05-14 2023-05-14 common stock 0 $23.15 15,000 direct
STOCK OPTION (RIGHT TO BUY) 66.25 2020-05-15 deemed execution date 0 ( ) 2016-05-13 2025-05-13 common stock 0 $66.25 5,000 direct
STOCK OPTION (RIGHT TO BUY) 99.62 2020-05-15 deemed execution date 0 ( ) 2017-05-24 2026-05-24 common stock 0 $99.62 8,000 direct
STOCK OPTION (RIGHT TO BUY) 134.51 2020-05-15 deemed execution date 0 ( ) 2018-05-15 2027-05-15 common stock 0 $134.51 6,500 direct
STOCK OPTION (RIGHT TO BUY) 381.97 2020-05-15 deemed execution date 0 ( ) 2019-05-16 2028-05-16 common stock 0 $381.97 4,000 direct
STOCK OPTION (RIGHT TO BUY) 266.39 2020-05-15 deemed execution date 0 ( ) 2020-05-30 2029-05-30 common stock 4,000 $266.39 4,000 direct
Footnotes
IDfootnote
f1 grant to reporting person of option to buy the number of shares of common stock set forth on table ii, column 7, under the abiomed, inc. 2008 stock incentive plan.
f2 these options become exerciseable in annual 25% increments, commencing on the date shown forth in table ii, column 6.
f3 these options become exercisable in annual 33-1/3% increments, commencing on the date shown in table ii, column 6.
f4 grant to reporting person of option to buy the number of shares of common stock set forth in table ii, column 7, under the abiomed, inc. 2015 omnibus incentive plan.
f5 transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
WhaleWisdom Logo

Elevate your investments